Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025

KIRKLAND, Wash., April 29, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) ("Kestra"), a wearable medical device and digital healthcare company, today announced the presentation of new real-world data on the ASSURE Wearable Cardioverter Defibrillator (WCD) at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society (HRS), held April 24–27 in San Diego. The abstract, titled "Real-world Experience with a Novel Wearable Cardioverter Defibrillator in a Community Setting: Advan ...